Gainers
- Summit Therapeutics (NASDAQ:SMMT) stock moved upwards by 33.1% to $4.1 during Thursday's regular session. Summit Therapeutics's stock is trading at a volume of 64.3 million shares as of 12:30 EST. This is 1496.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $825.4 million.
- BioVie (NASDAQ:BIVI) shares rose 31.66% to $7.75. BioVie's stock is trading at a volume of 4.0 million shares as of 12:30 EST. This is 560.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $236.7 million.
- Nymox Pharmaceutical (NASDAQ:NYMX) shares rose 28.43% to $0.64. Nymox Pharmaceutical's stock is trading at a volume of 1.0 million shares as of 12:30 EST. This is 734.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $57.5 million.
- Entrada Therapeutics (NASDAQ:TRDA) shares rose 19.41% to $21.16. Entrada Therapeutics's stock is trading at a volume of 239.4K shares as of 12:30 EST. This is 360.3% of its average full-day volume over the last 100 days. The company's market cap stands at $664.5 million.
- Celcuity (NASDAQ:CELC) stock moved upwards by 18.8% to $8.97. The company's market cap stands at $138.6 million.
- Otonomy (NASDAQ:OTIC) shares rose 17.39% to $0.14. Trading volume for Otonomy's stock is 4.8 million as of 12:30 EST. This is 41.3% of its average full-day volume over the last 100 days. The company's market cap stands at $8.2 million.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Losers
- Eiger BioPharmaceuticals (NASDAQ:EIGR) stock fell 70.3% to $1.14 during Thursday's regular session. Trading volume for Eiger BioPharmaceuticals's stock is 11.5 million as of 12:30 EST. This is 3348.0% of its average full-day volume over the last 100 days. The company's market cap stands at $50.2 million.
- Relmada Therapeutics (NASDAQ:RLMD) shares fell 50.05% to $2.08. Relmada Therapeutics's stock is trading at a volume of 5.2 million shares as of 12:30 EST. This is 473.7% of its average full-day volume over the last 100 days. The company's market cap stands at $62.5 million.
- Cano Health (NYSE:CANO) stock decreased by 19.6% to $1.38. As of 12:30 EST, this security is trading at a volume of 18.9 million shares, making up 159.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $336.2 million.
- TransCode Therapeutics (NASDAQ:RNAZ) stock declined by 19.49% to $0.79. Trading volume for TransCode Therapeutics's stock is 18.6 million as of 12:30 EST. This is 754.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $10.2 million.
- Instil Bio (NASDAQ:TIL) shares declined by 17.63% to $1.0. As of 12:30 EST, Instil Bio's stock is trading at a volume of 1.0 million, which is 169.7% of its average full-day volume over the last 100 days. The company's market cap stands at $130.4 million.
- Cosmos Holdings (NASDAQ:COSM) stock declined by 15.3% to $0.38. The current volume of 24.6 million shares is 49.5% of Cosmos Holdings's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $68.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.